Published in Medical Devices and Surgical Technology Week, July 31st, 2011
The 6Fr size allows a smaller access site and multiple approach options when treating patients with peripheral artery disease (PAD), which can be particularly important when treating stenoses or occlusions in the superficial femoral artery (SFA) and the popliteal...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Devices and Surgical Technology Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.